share_log

HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target

HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target

HC Wainwright & Co.重申买入 Biotricity,维持2美元的目标价
Benzinga Real-time News ·  2023/02/15 06:08

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and maintains $2 price target.

HC Wainwright&Co.分析师凯文·迪德重申了生物科技(纳斯达克:BTCY)的买入计划,并维持2美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发